Skip to main content


TreeFrog Therapeutics Secures $75m In Series B Financing from Group Including Leonard Green To Advance A Pipeline Of Stem Cell-Derived Cell Therapies And Deploy Proprietary C-Stem(TM) Technology In The USA & Japan

BORDEAUX, France. (September, 13, 2021) - TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, today announced the successful closing of a $75 million (EUR64M) Series B…
Read More